GlassScriptPhysician profile
Bradley W Steele
NPI 1811940646
$12,197.51
in general payments reported to CMS, 2019-2025
60 companies · $2,655 in 2025
The $2,655 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,411 · 2020: $1,081 · 2021: $1,551 · 2022: $1,666 · 2023: $1,844 · 2024: $1,989 · 2025: $2,655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,453 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,453.24 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $1,248.45 | 2020-2025 | Provenge |
| Boston Scientific Corporation | $1,008.63 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700, Rezum Generator |
| Astellas Pharma US INC | $909.94 | 2019-2025 | Xtandi, Veozah |
| Janssen Biotech, INC. | $871.08 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Merck Sharp & Dohme LLC | $706.07 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Pfizer INC. | $626.74 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $571.87 | 2019-2024 | Xiaflex, Aveed |
| Coloplast Corp | $525.08 | 2019-2024 | Titan, Speedicath |
| Bayer Healthcare Pharmaceuticals INC. | $376.87 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $374.43 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $360.84 | 2022-2025 | Botox |
| Teleflex LLC | $348.26 | 2021-2025 | Urolift, Barrigel, Deknatel |
| Medtronic, INC. | $308.40 | 2021-2025 | Interstim |
| Angiodynamics, INC. | $253.84 | 2023-2025 | Nanoknife |
| Urogen Pharma, INC. | $248.13 | 2021-2025 | Jelmyto |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.